[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neisseria Gonorrhoeae Infections Treatment Market Data Survey Report 2025

January 2018 | 66 pages | ID: GB6D0254F09EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The global Neisseria Gonorrhoeae Infections Treatment market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Allergan Plc 
  • BioDiem Ltd 
  • Biolytics Pharma 
  • Debiopharm International SA 
  • F. Hoffmann-La Roche Ltd. 
  • GlaxoSmithKline Plc 
  • GlaxoSmithKline Plc 
  • Paratek Pharmaceuticals, Inc. 
  • Recce Pty Ltd 
  • Redx Pharma Plc 
  • Sarepta Therapeutics, Inc. 
  • Sumitomo Dainippon Pharma Co., Ltd

Major Applications as follows:
  • Clinic 
  • Hospital 
  • Others

Major Type as follows:
  • Cribrostatin-6 
  • Dalbavancin 
  • Debio-1453 
  • Gepotidacin Mesylate 
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Allergan Plc
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 BioDiem Ltd
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biolytics Pharma
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Debiopharm International SA
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 F. Hoffmann-La Roche Ltd.
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GlaxoSmithKline Plc
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GlaxoSmithKline Plc
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Paratek Pharmaceuticals, Inc.
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Recce Pty Ltd
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Redx Pharma Plc
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Sarepta Therapeutics, Inc.
3.12 Sumitomo Dainippon Pharma Co., Ltd

4 MAJOR APPLICATION

4.1 Clinic
  4.1.1 Overview
  4.1.2 Clinic Market Size and Forecast
4.2 Hospital
  4.2.1 Overview
  4.2.2 Hospital Market Size and Forecast
4.3 Others
  4.3.1 Overview
  4.3.2 Others Market Size and Forecast

5 MARKET BY TYPE

5.1 Cribrostatin-6
  5.1.1 Overview
  5.1.2 Cribrostatin-6 Market Size and Forecast
5.2 Dalbavancin
  5.2.1 Overview
  5.2.2 Dalbavancin Market Size and Forecast
5.3 Debio-1453
  5.3.1 Overview
  5.3.2 Debio-1453 Market Size and Forecast
5.4 Gepotidacin Mesylate
  5.4.1 Overview
  5.4.2 Gepotidacin Mesylate Market Size and Forecast
5.5 Others
  5.5.1 Overview
  5.5.2 Others Market Size and Forecast
5.6 Others
  5.6.1 Overview
  5.6.2 Others Market Size and Forecast

6 CONCLUSION

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Allergan Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of BioDiem Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Biolytics Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Debiopharm International SA
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of Paratek Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Recce Pty Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Redx Pharma Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of Sarepta Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Sumitomo Dainippon Pharma Co., Ltd

LIST OF FIGURES

Fig Global Neisseria Gonorrhoeae Infections Treatment Market Size and CAGR 2011-2017 (Million USD)
Fig Global Neisseria Gonorrhoeae Infections Treatment Market Size and CAGR 2011-2017 (Volume)
Fig Global Neisseria Gonorrhoeae Infections Treatment Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Neisseria Gonorrhoeae Infections Treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Clinic Market Size and CAGR 2011-2017 (Million USD)
Fig Clinic Market Size and CAGR 2011-2017 (Volume)
Fig Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2011-2017 (Million USD)
Fig Hospital Market Size and CAGR 2011-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Cribrostatin-6 Market Size and CAGR 2011-2017 (Million USD)
Fig Cribrostatin-6 Market Size and CAGR 2011-2017 (Volume)
Fig Cribrostatin-6 Market Forecast and CAGR 2018-2025 (Million USD)
Fig Cribrostatin-6 Market Forecast and CAGR 2018-2025 (Volume)
Fig Dalbavancin Market Size and CAGR 2011-2017 (Million USD)
Fig Dalbavancin Market Size and CAGR 2011-2017 (Volume)
Fig Dalbavancin Market Forecast and CAGR 2018-2025 (Million USD)
Fig Dalbavancin Market Forecast and CAGR 2018-2025 (Volume)
Fig Debio-1453 Market Size and CAGR 2011-2017 (Million USD)
Fig Debio-1453 Market Size and CAGR 2011-2017 (Volume)
Fig Debio-1453 Market Forecast and CAGR 2018-2025 (Million USD)
Fig Debio-1453 Market Forecast and CAGR 2018-2025 (Volume)
Fig Gepotidacin Mesylate Market Size and CAGR 2011-2017 (Million USD)
Fig Gepotidacin Mesylate Market Size and CAGR 2011-2017 (Volume)
Fig Gepotidacin Mesylate Market Forecast and CAGR 2018-2025 (Million USD)
Fig Gepotidacin Mesylate Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)


More Publications